Yes, vitamin D injections are generally safe when administered by a qualified healthcare provider
In July 2026, an FDA advisory committee (the Pharmacy Compounding Advisory Committee, or PCAC) voted to recommend that several peptides including BPC-157, TB-500, KPV, and MOTS-c be considered for inclusion on the 503A compounding list
To facilitate delivery of MDPP in a non-clinical community setting (to align with the certified DPP model tested by The CMS Innovation Center), CMS created a new MDPP supplier type through rulemaking in the CY 2017 PFS final rule (81 FR 80471), in addition to requiring organizations that wish to participate in MDPP to enroll in Medicare separately, even if they are already enrolled in Medicare for other purposes
For TB-500 / thymosin beta-4, the supportive rationale is the well-documented role of thymosin beta-4 in actin regulation, cell migration and wound healing again, largely from cell and animal models rather than human recovery trials